Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its fourth quarter revenues grew 9 percent year over year.

For the three months ended Oct. 31, the life sciences company said total revenues rose to $1.29 billion from $1.19 billion in Q4 2017, beating the analysts' average estimate of $1.25 billion. Core revenues also rose 9 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.